Shi Yong Neo (Shiyong Neo)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Inflammatory Response

Nitric Oxide Synthase

Top Venues

Journal for immunotherapy of cancer

Science translational medicine

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Shi Yong Neo, Le Tong, Joni Chong, Yaxuan Liu, Xu Jing, Mariana M S Oliveira, Yi Chen, Ziqing Chen, Keene Lee, Nutsa Burduli, Xinsong Chen, Juan Gao, Ran Ma, Jia Pei Lim, Jianxin Huo, Shengli Xu, Evren Alici, Stina Linnea Wickström, Felix Haglund, Johan Hartman, Arnika Kathleen Wagner, Yihai Cao, Rolf Kiessling, Kong Peng Lam, Lisa S Westerberg, Andreas Lundqvist
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis. Science translational medicine 16 (747) (2024)
Shi Yong Neo, Le Tong, Joni Chong, Yaxuan Liu, Xu Jing, Mariana M S Oliveira, Yi Chen, Ziqing Chen, Keene Lee, Nutsa Burduli, Xinsong Chen, Juan Gao, Ran Ma, Jia Pei Lim, Jianxin Huo, Shengli Xu, Evren Alici, Stina Linnea Wickström, Felix Haglund, Johan Hartman, Arnika Kathleen Wagner, Yihai Cao, Rolf Kiessling, Kong Peng Lam, Lisa S Westerberg, Andreas Lundqvist
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis. Science translational medicine 16 (747) (2024)
Sonia Cismas, Sylvya Pasca, Caitrin Crudden, Iara Troccoli Drakensjo, Naida Suleymanova, Simin Zhang, Benjamin Gebhard, Dawei Song, Shi Yong Neo, Takashi Shibano, Terry J Smith, George Adrian Calin, Ada Girnita, Leonard Girnita
Competing engagement of β-arrestin isoforms balances IGF1R/p53 signaling and controls melanoma cell chemotherapeutic responsiveness. Molecular cancer research : MCR (2023)
Shi Yong Neo, Shengli Xu, Joni Chong, Kong Peng Lam, Jing Wu
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer. Journal for immunotherapy of cancer 11 (4) (2023)
Shi Yong Neo, Shengli Xu, Joni Chong, Kong Peng Lam, Jing Wu
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer. Journal for immunotherapy of cancer 11 (4) (2023)
Shi Yong Neo, Shengli Xu, Joni Chong, Kong Peng Lam, Jing Wu
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer. Journal for immunotherapy of cancer 11 (4) (2023)